Clinical Trials Logo
  1. Home
  2. Precancerous Conditions
  3. NCT00314262

Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor

Precancerous Conditions Clinical Trial

Official title:
Phase I/II Study of Chemoprevention With Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Erlotinib (OSI-774, Tarceva) and Cyclooxygenase-2 (COX-2) Inhibitor (Celecoxib) in Premalignant Lesions of Head and Neck of Former Smokers

Clinical Trial Summary

Evaluate effect on cells and patient response to study medications, assess side effects of these medications, and evaluate chemicals in cells that may tell how the drug works, before, and after receiving the study medications.

Clinical Trial Description

The purpose of this study is to evaluate the effect on cells and patient response to study medications, assess the side effects of these medications, and to evaluate chemicals in the cells that may tell how the drug works, before, and after receiving the study medications.

Approximately 61 patients will participate at Emory Winship Cancer Institute and Emory Crawford W. Long Hospital in Atlanta, Georgia. ;

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00314262
Study type Interventional
Source Emory University
Contact
Status Completed
Phase Phase 1/Phase 2
Start date October 2006
Completion date November 2012
View Details
See also
  Status Clinical Trial Phase
Completed NCT05215860 - Photographic Evidence of Oral Precancerous Lesions in Current Tobacco and Areca Nut Users Improves Their Quit Rates N/A
Completed NCT04153266 - Oral Epithelial Dysplasia Informational Needs Questionnaire
Completed NCT01752114 - Early Diagnosis of Pulmonary Nodules N/A
Completed NCT01752101 - Identification of a Plasma Proteomic Signature for Lung Cancer N/A
Completed NCT00179361 - Natural History of Oro-pharyngeal Cancer Precursors N/A
Completed NCT00036283 - Chemoprevention of Oral Premalignant Lesions Phase 2
Recruiting NCT06165614 - Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya Phase 1
Not yet recruiting NCT01837693 - Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2 N/A
Completed NCT00043615 - Collection of Blood, Bone Marrow, Tumor or Tissue Samples N/A
Active, not recruiting NCT02158858 - A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis Phase 1/Phase 2
Completed NCT02323672 - Salivary and Serum Levels of Chemerin and MMP-9 in Oral Premalignant and Malignant Lesions N/A
Completed NCT00851305 - Detection of Early Gastric Cancers Using Confocal Laser Endomicroscopy N/A
Not yet recruiting NCT04065737 - Sintilimab to Prevent High-risk Oral Premalignant Lesions Cancerization Phase 2
Active, not recruiting NCT00655421 - Oral Cancer Screening in Mumbai, India by Primary Health Care Workers Phase 3
Completed NCT00213603 - Follow-up Modalities of Low Grade Precancerous Bronchial Lesions N/A
Completed NCT03100045 - Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3) Phase 1